Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
Jessica L. Yecies, Huihui Zhang, Suchithra Menon et al. · Cell Metabolism · 2011
Cited by 657 works. doi:10.1016/j.cmet.2011.06.002 Open-access PDF
Authors
- Jessica L. Yecies
- Huihui Zhang
- Suchithra Menon
- Sihao Liu
- Derek William Yecies
- Alex I. Lipovsky
- Cem Z. Görgün
- David J. Kwiatkowski
- Gökhan S. Hotamışlıgil
- Chih‐Hao Lee
- Brendan D. Manning
References
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
- SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
- SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
- Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
- Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathway
- Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells.
- Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
- A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells
- Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes
- Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice